Skip to Content

Lidocaine Hydrochloride and 5% Dextrose Injection

Last Updated: May 26, 2016
Status: Resolved

Products Affected - Description
    • Lidocaine and 5% Dextrose injection, Pfizer, 4 mg/mL, 250 mL premixed bag, 12 count, NDC 00409-7931-32
    • Lidocaine and 5% Dextrose injection, Pfizer, 4 mg/mL, 500 mL premixed bag, 24 count, NDC 00409-7931-24
    • Lidocaine and 5% Dextrose injection, Pfizer, 8 mg/mL, 250 mL premixed bag, 12 count, NDC 00409-7939-32
Reason for the Shortage
    • Hospira discontinued lidocaine premixed bags.
    • BBraun and Baxter have lidocaine premixed bags available.
Available Products
    • Lidocaine and 5% Dextrose injection, BBraun, 4 mg/mL, 250 mL premixed bag, 1 count, NDC 00264-9594-20
    • Lidocaine and 5% Dextrose injection, BBraun, 4 mg/mL, 500 mL premixed bag, 1 count, NDC 00264-9594-10
    • Lidocaine and 5% Dextrose injection, BBraun, 8 mg/mL, 250 mL premixed bag, 1 count, NDC 00264-9598-20
    • Lidocaine and 5% Dextrose injection, Baxter, 4 mg/mL, 500 mL premixed bag, 18 count, NDC 00338-0409-03
    • Lidocaine and 5% Dextrose injection, Baxter, 8 mg/mL, 250 mL premixed bag, 24 count, NDC 00338-0411-02

Estimated Resupply Dates

    • All currently marketed presentations are available.

Updated

Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 11, 2011 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer